
EU ESG Ratings Reform: New Transparency Rules for Chemical Companies
The European Commission is standardizing ESG rating methodology to address inconsistency. Learn what new transparency rules mean for chemical sector disclosure and compliance.

Fatima Noor
Aug 30, 2026
McKinsey analysis revealed that chemical companies with greener product portfolios delivered superior total shareholder returns compared to less-sustainable competitors. That research carried significant weight in boardrooms and procurement departments alike. But the data came from a different era, one before the chemical industry faced its sharpest overcapacity downcycle in years. Now in 2026, producers are slashing capital expenditure and deferring sustainability investments to preserve cash. The critical question for traders, procurement managers and industry buyers is whether the green-premium thesis still holds water when margins are under severe pressure.
The McKinsey study examined total shareholder return performance across major chemical producers and found a clear correlation between sustainability-focused portfolios and financial outperformance. Companies that had invested in greener chemistries, bio-based feedstocks and circular economy solutions consistently beat their peers on TSR metrics. The research suggested that sustainability was not just a compliance cost or marketing exercise but a genuine value driver. Investors rewarded companies with credible transition strategies and product portfolios aligned with decarbonization trends.
Several factors explained this outperformance. Green products often commanded price premiums in end markets where customers faced their own sustainability mandates. These products also showed greater resilience during regulatory shifts and carbon pricing mechanisms. Companies with sustainable portfolios attracted ESG-focused capital at lower costs. The thesis was compelling and influenced strategic planning across the sector.
The chemical industry is now navigating a brutal downcycle defined by massive overcapacity, particularly in Asia. Demand growth has stalled in key regions while new production capacity continues to come online. Margins are compressed across most value chains. In this environment, chemical producers are making hard choices about capital allocation. Sustainability projects that looked attractive two years ago are being delayed or cancelled. Capital expenditure budgets are under intense scrutiny.
This shift raises uncomfortable questions about the durability of the green-premium advantage. When survival becomes the priority, do sustainable portfolios still deliver measurable financial benefits? Or does the TSR outperformance disappear when the entire sector is under pressure?
Chemical producers are deferring sustainability investments for several practical reasons. First, green chemistry projects and bio-based facilities typically require higher upfront capital than conventional expansions. In a downcycle, access to capital becomes more expensive and scarce. Second, the payback periods for sustainability projects often extend beyond the typical three to five year horizon that CFOs are willing to accept during downturns. Third, demand for premium-priced green products softens when end customers face their own margin pressures.
The result is a wave of project delays and cancellations across the sector. Companies are prioritizing maintenance capex and essential safety investments over transformational sustainability initiatives. This pragmatic approach may preserve short-term liquidity but risks undermining long-term competitive positioning.
The real test of the green-premium thesis comes during downcycles when buyers become extremely price-sensitive. Procurement managers facing budget cuts will naturally gravitate toward the lowest-cost options that meet specifications. This behavior puts pressure on premium-priced sustainable products. However, the picture is more nuanced than simple price competition.
Several factors continue to support green product demand even in weak markets:
Regulatory mandates remain in force regardless of the economic cycle. Customers in the EU and other regulated markets must meet sustainability targets and cannot simply switch back to conventional products to save money.
Long-term supply agreements for bio-based and circular products often include volume commitments that provide stability even when spot markets weaken.
Brand reputation considerations mean that major consumer goods companies continue to demand sustainable inputs to protect their own ESG credentials.
Carbon pricing mechanisms in key markets make conventional products relatively more expensive as emissions costs rise.
The green premium may compress during downcycles but it does not disappear entirely for products with genuine regulatory or brand-driven demand.
Not all sustainable chemical portfolios are experiencing the same pressure. Performance varies significantly by segment and application. Bio-based polymers serving packaging applications face intense competition as e-commerce growth slows and brand budgets tighten. However, sustainable chemicals in regulated sectors show more resilience.
Products serving the pharmaceutical industry maintain premiums due to stringent quality and sustainability requirements. Water treatment chemicals with green certifications continue to see steady demand from municipal and industrial customers facing discharge regulations. Agricultural inputs with lower environmental impact profiles benefit from farmer economics and policy support even when commodity prices weaken.
The key distinction is whether the green product solves a regulatory problem or delivers measurable cost savings to the end user. Products that do both show the greatest downcycle resilience.

Buyers navigating this environment need to separate genuine sustainability advantages from marketing claims. The downcycle is exposing which green products have real value and which were premium-priced based on temporary market enthusiasm. Procurement managers should focus on several key indicators.
First, examine whether suppliers are maintaining their sustainability R&D budgets despite overall capex cuts. Companies that continue investing in green chemistry during downturns are positioning for the next upcycle. Second, look for products with regulatory tailwinds that cannot be easily reversed. Third, assess whether the green premium is justified by total cost of ownership including carbon costs, waste reduction and efficiency gains.
The downcycle also creates opportunities. Suppliers with strong sustainable portfolios may be more willing to negotiate on price to maintain volume. Long-term agreements signed during weak markets can lock in favorable terms. Buyers with credible sustainability commitments gain leverage in negotiations.
The McKinsey TSR thesis is being stress-tested by the 2026 downcycle but it is not broken. Sustainable chemical portfolios continue to deliver value, though the magnitude of outperformance has compressed. The green premium persists where regulatory mandates, brand requirements and total cost economics support it. However, products positioned solely on sustainability marketing without functional or regulatory advantages are losing ground.
For procurement teams, the downcycle demands more sophisticated evaluation of green claims and supplier strategies. The companies that maintain their sustainability commitments through the downturn will likely emerge with stronger market positions when conditions improve. Buyers who recognize this dynamic can build supply chain resilience while advancing their own ESG goals.
Ready to source sustainable chemicals from verified global suppliers? Explore competitive offers on our platform today.

Featured Product
Found this useful?
Continue Reading

The European Commission is standardizing ESG rating methodology to address inconsistency. Learn what new transparency rules mean for chemical sector disclosure and compliance.

US chemical industry employment remains flat through 2027 while average pay exceeds $108,000. This workforce data reveals critical insights about capex caution and industry health for procurement professionals.

Oliver Wyman’s 2026 outlook identifies performance transformation as the dominant theme for chemical producers. See how structural cost reduction is replacing sustainability spending as the primary strategic priority during the downcycle